BARBARA GLEESON, MSN, APN, C
Family Medicine Physician in PENNSAUKEN, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
BARBARA GLEESON, MSN, APN, C filed 4,302 Medicare Part D claims in 2023 as a Family Medicine Physician in PENNSAUKEN, New Jersey, prescribing 84% generic.
- 4K
- Part D claims, 2023
- 84%
- generic prescribing
- $2.0K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
BARBARA GLEESON, MSN, APN, C's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
4,302 Top 8% higher than 92% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
BARBARA GLEESON, MSN, APN, C practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about BARBARA GLEESON, MSN, APN, C?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New Jersey
How Family Medicine Physician compares to other specialties among New Jersey providers
Family Medicine Physician share within New Jersey
Family Medicine Physician is one of the more visible NUCC categories in New Jersey
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Family Medicine Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Family Medicine Physician ABMS/AOA estimate
Est. board-certified rate (Family Medicine Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Family Medicine Physician US NPIs
Specialty board-certified rate — Family Medicine Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
BARBARA GLEESON, MSN, APN, C appears in the CMS NPPES registry as a Family Medicine Physician provider holding MSN, APN, C credentials at 6981 N PARK DR, PENNSAUKEN, NJ, 08109, with a listed phone of (856) 663-4949. NPI 1922087311 was issued on 01/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GLEESON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 4,302 prescription claims written by this provider, covering 324 Medicare beneficiaries and totaling roughly $620K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 1.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Family Medicine Physician is a high-volume specialty nationwide, with 147,640 enrolled providers across 56 states and an average of 3,418 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1922087311 |
|---|---|
| Specialty | Family Medicine Physician |
| Credentials | MSN, APN, C |
| Gender | Female |
| NPI Issued | 01/13/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm BARBARA GLEESON, MSN, APN, C's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BARBARA GLEESON, MSN, APN, C. Source: openpaymentsdata.cms.gov.
Total received
$2.0K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 4,302 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 9,357
- Total Day Supply
- 274,110
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $516K
- Generic Drug Cost
- $103K
- Opioid Claims
- 47 (1.1% rate)
- Antibiotic Claims
- 59
Patient Demographics
- Average Patient Age
- 71.0 years
- Avg HCC Risk Score
- 1.07
- Gender Split
- 79% female / 21% male
- Age Distribution
- <65: 53, 65-74: 161, 75-84: 86, 85+: 24
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What BARBARA GLEESON, MSN, APN, C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
314 claims
- Levothyroxine Sodium
Levothyroxine Sodium
156 claims
- Lisinopril
Lisinopril
155 claims
- Amlodipine Besylate
Amlodipine Besylate
148 claims
- Albuterol Sulfate … 104
Albuterol Sulfate Hfa
104 claims
- Famotidine 104
Famotidine
104 claims
- Metformin Hcl Er 99
Metformin Hcl Er
99 claims
- Metoprolol Succinate 97
Metoprolol Succinate
97 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 314 |
| Levothyroxine Sodium | 156 |
| Lisinopril | 155 |
| Amlodipine Besylate | 148 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 104 |
| Famotidine | 104 |
| Metformin Hcl Er Metformin Hcl | 99 |
| Metoprolol Succinate | 97 |
| Hydrochlorothiazide | 92 |
| Farxiga Dapagliflozin Propanediol | 89 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Medicine Physician Overview
How BARBARA GLEESON, MSN, APN, C fits within the Family Medicine Physician landscape nationally.
BARBARA GLEESON, MSN, APN, C's 4,302 claims are above the specialty average of 3,418.
Nearby Family Medicine Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as GLEESON.
Compare Family Medicine Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is BARBARA GLEESON, MSN, APN, C's specialty? ▼
How much does BARBARA GLEESON, MSN, APN, C prescribe under Medicare Part D? ▼
Where is BARBARA GLEESON, MSN, APN, C located? ▼
What is BARBARA GLEESON, MSN, APN, C's NPI number? ▼
Does BARBARA GLEESON, MSN, APN, C prescribe more brand-name or generic drugs? ▼
Does BARBARA GLEESON, MSN, APN, C prescribe opioids? ▼
How many Family Medicine Physician providers are there in the US? ▼
What drugs does BARBARA GLEESON, MSN, APN, C prescribe most often? ▼
Does BARBARA GLEESON, MSN, APN, C accept Medicare? ▼
How can I verify BARBARA GLEESON, MSN, APN, C's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology